← Insider buys
RYTM

Rhythm Pharmaceuticals, Inc. · Healthcare

Chief Technical Officer Joseph Shulman sold $608K of Rhythm Pharmaceuticals, Inc.

Sold$608,210
$119.75Price
5,079Shares
−24%Stake

What RYTM did after the filing

Filed Aug 17Copier in Aug 18
The stock from Tue, Aug 18 open, $115.25
−17.4%
S&P 500, same days
−0.8%

Measured over 30 trading days, to the Sep 30 close.

Traded Thu, Aug 13. Filed Mon, Aug 17, 6:00 PM ET, after the close. Returns use the Aug 18 open and the Sep 30 close. Not investment advice.